Wockhardt's Q3 FY 2025-26 Quarterly Results
- 11 Feb 2026
Result Summary
- Wockhardt Ltd reported a 13.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 25.2%.
- Its expenses for the quarter were up by 17.4% QoQ and 18.1% YoY.
- The net profit decreased 25.6% QoQ and increased 205.0% YoY.
- The earnings per share (EPS) of Wockhardt Ltd stood at 3.61 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 913.00 | 803.00 | 729.00 | 13.7% | 25.2% |
Total Expenses | 836.00 | 712.00 | 708.00 | 17.4% | 18.1% |
Profit Before Tax | 67.00 | 91.00 | 21.00 | -26.4% | 219.0% |
Tax | 6.00 | 9.00 | 1.00 | -33.3% | 500.0% |
Profit After Tax | 61.00 | 82.00 | 20.00 | -25.6% | 205.0% |
Earnings Per Share | 3.61 | 4.81 | 0.91 | -24.9% | 296.7% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Wockhardt Ltd is a global pharmaceutical and biotechnology company headquartered in India. It is primarily engaged in the development, manufacturing, and marketing of pharmaceutical formulations, biopharmaceuticals, nutrition products, vaccines, and active pharmaceutical ingredients (APIs). The company operates in the healthcare industry, with a focus on providing innovative solutions for the treatment of various diseases. Wockhardt has a significant presence in both domestic and international markets, offering a diverse portfolio of products. Recent developments and specific strategic initiatives of the company are not available within the provided data set.
Revenue
For the third quarter of the fiscal year 2026 (Q3FY26), Wockhardt Ltd reported total income of ₹913.00 crores, reflecting a robust growth of 13.7% quarter-over-quarter (QoQ) from ₹803.00 crores in Q2FY26, and a substantial year-over-year (YoY) increase of 25.2% from ₹729.00 crores in Q3FY25. This increase in revenue indicates a strong performance in the company's sales operations over the past year. The revenue growth can be attributed to the company's ongoing efforts to expand its market reach and enhance its product offerings.
Profitability
In Q3FY26, Wockhardt Ltd's profitability metrics showcased mixed performance. The Profit Before Tax (PBT) was reported at ₹67.00 crores, which represents a decline of 26.4% QoQ from ₹91.00 crores in Q2FY26, yet an impressive growth of 219.0% YoY from ₹21.00 crores in Q3FY25. The Profit After Tax (PAT) for Q3FY26 was ₹61.00 crores, marking a decrease of 25.6% QoQ from ₹82.00 crores in Q2FY26, but a significant increase of 205.0% YoY from ₹20.00 crores in Q3FY25. The tax expense for Q3FY26 was ₹6.00 crores, reduced by 33.3% QoQ, but up 500.0% YoY, reflecting changes in the company's tax liabilities over the periods.
Operating Metrics
Operating metrics for Wockhardt Ltd in Q3FY26 demonstrated an increase in total expenses, which amounted to ₹836.00 crores, up 17.4% QoQ from ₹712.00 crores in Q2FY26, and a 18.1% rise YoY from ₹708.00 crores in Q3FY25. The Earnings Per Share (EPS) for Q3FY26 stood at ₹3.61, showing a decline of 24.9% QoQ from ₹4.81 in Q2FY26, yet a notable increase of 296.7% YoY from ₹0.91 in Q3FY25. These metrics highlight the company's operational cost dynamics and shareholder value generation over the reviewed periods. The data reflects the company's ongoing financial strategy and operational adjustments in response to market conditions.